HZNP - Amgen said in advanced talks to buy Horizon Therapeutics for well over $20B - WSJ
- Amgen Inc. ( NASDAQ: AMGN ) is in advance discussions to purchase Horizon Therapeutics ( NASDAQ: HZNP ) in a deal that may be valued at well over $20 billion.
- An agreement may be finalized as soon as Monday, according to a WSJ report, which cited people familiar. Amgen ( AMGN ) was the last of three suitors left for Horizon ( HRZN ).
- Sanofi ( NASDAQ: SNY ) said it's no longer in discussions to purchase Horizon ( HZNP ), according to a statement.
- Developing story ...
For further details see:
Amgen said in advanced talks to buy Horizon Therapeutics for well over $20B - WSJ